Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2025 Filed Jun 5, 2025 20:34 UTC |
Cook Jennifer E.Director
|
GrantCommon Stock | 6,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-25-000142 · wk-form4_1749155629.xml · nonDerivative · entry 1 Cook Jennifer E. · CIK 0001754371 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,075 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 6,037 unvested RSUs. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:33 UTC |
FLATLEY JAY TDirector
|
GrantStock Option (right to buy) · Derivative | 18,111 | $0.00 Strike: $13.93 | $0.00 |
DisclosureSEC source: 0001714899-25-000141 · wk-form4_1749155513.xml · derivative · entry 3 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,111 Underlying: Common Stock · 18,111 shares Expires 2035-06-03 F4 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:33 UTC |
FLATLEY JAY TDirector
|
GrantCommon Stock | 6,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-25-000141 · wk-form4_1749155513.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,220 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 6,037 unvested RSUs. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:31 UTC |
Klein Peter SDirector
|
GrantStock Option (right to buy) · Derivative | 18,111 | $0.00 Strike: $13.93 | $0.00 |
DisclosureSEC source: 0001714899-25-000140 · wk-form4_1749155428.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,111 Underlying: Common Stock · 18,111 shares Expires 2035-06-03 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:31 UTC |
Klein Peter SDirector
|
GrantCommon Stock | 6,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-25-000140 · wk-form4_1749155428.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,533 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 6,037 unvested RSUs. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:29 UTC |
Krognes Steve E.Director
|
GrantStock Option (right to buy) · Derivative | 18,111 | $0.00 Strike: $13.93 | $0.00 |
DisclosureSEC source: 0001714899-25-000139 · wk-form4_1749155311.xml · derivative · entry 3 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,111 Underlying: Common Stock · 18,111 shares Expires 2035-06-03 F4 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:29 UTC |
Krognes Steve E.Director
|
GrantCommon Stock | 6,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-25-000139 · wk-form4_1749155311.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,794 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 6,037 unvested RSUs. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:26 UTC |
Schenkein David PDirector
|
GrantStock Option (right to buy) · Derivative | 18,111 | $0.00 Strike: $13.93 | $0.00 |
DisclosureSEC source: 0001714899-25-000138 · wk-form4_1749155084.xml · derivative · entry 4 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,111 Underlying: Common Stock · 18,111 shares Expires 2035-06-03 F5 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:26 UTC |
Schenkein David PDirector
|
GrantCommon Stock | 6,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-25-000138 · wk-form4_1749155084.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,257 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 6,037 unvested RSUs. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:25 UTC |
Thornberry NancyDirector
|
GrantStock Option (right to buy) · Derivative | 18,111 | $0.00 Strike: $13.93 | $0.00 |
DisclosureSEC source: 0001714899-25-000137 · wk-form4_1749154899.xml · derivative · entry 2 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,111 Underlying: Common Stock · 18,111 shares Expires 2035-06-03 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:25 UTC |
Thornberry NancyDirector
|
GrantCommon Stock | 6,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-25-000137 · wk-form4_1749154899.xml · nonDerivative · entry 1 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,717 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 6,037 unvested RSUs. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:23 UTC |
Tessier-Lavigne MarcDirector
|
GrantStock Option (right to buy) · Derivative | 18,111 | $0.00 Strike: $13.93 | $0.00 |
DisclosureSEC source: 0001714899-25-000136 · wk-form4_1749154932.xml · derivative · entry 5 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,111 Underlying: Common Stock · 18,111 shares Expires 2035-06-03 F6 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:23 UTC |
Tessier-Lavigne MarcDirector
|
GrantCommon Stock | 6,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-25-000136 · wk-form4_1749154932.xml · nonDerivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,886,576 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 6,037 unvested RSUs. Read SEC document |
| January 07, 2025 Filed Jan 9, 2025 01:24 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 7,650 | $20.81 | $159,196.50 |
DisclosureSEC source: 0001714899-25-000049 · wk-form4_1736385877.xml · nonDerivative · entry 2 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,071 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F3 · balance_after: Includes 177,940 Unvested RSUs. Read SEC document |
| January 07, 2025 Filed Jan 9, 2025 01:25 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,907 | $20.81 | $60,494.67 |
DisclosureSEC source: 0001714899-25-000050 · wk-form4_1736385937.xml · nonDerivative · entry 2 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,308 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F3 · balance_after: Includes 134,030 Unvested RSUs. Read SEC document |
| January 07, 2025 Filed Jan 9, 2025 01:23 UTC |
Krognes Steve E.Director
|
SaleCommon Stock | 3,339 | $20.81 | $69,484.59 |
DisclosureSEC source: 0001714899-25-000048 · wk-form4_1736385830.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,757 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · balance_after: Includes 5,967 Unvested RSUs. Read SEC document |
| January 07, 2025 Filed Jan 9, 2025 01:26 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 2,907 | $20.81 | $60,494.67 |
DisclosureSEC source: 0001714899-25-000051 · wk-form4_1736385991.xml · nonDerivative · entry 2 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,673 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F3 · balance_after: Includes 134,030 Unvested RSUs. Read SEC document |
| January 06, 2025 Filed Jan 9, 2025 01:24 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 29,266 | $20.22 | $591,758.52 |
DisclosureSEC source: 0001714899-25-000049 · wk-form4_1736385877.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,721 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.91 to $20.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 177,940 Unvested RSUs. Read SEC document |
| January 06, 2025 Filed Jan 9, 2025 01:25 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 12,255 | $20.22 | $247,796.10 |
DisclosureSEC source: 0001714899-25-000050 · wk-form4_1736385937.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,215 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.91 to $20.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 134,030 Unvested RSUs. Read SEC document |
| January 06, 2025 Filed Jan 9, 2025 01:26 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 12,255 | $20.22 | $247,796.10 |
DisclosureSEC source: 0001714899-25-000051 · wk-form4_1736385991.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,580 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.93 to $20.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 134,030 Unvested RSUs. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 23:59 UTC |
Watts Ryan J.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 162,540 | $0.00 Strike: $21.26 | $0.00 |
DisclosureSEC source: 0001714899-25-000028 · wk-form4_1736294379.xml · derivative · entry 3 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,540 Underlying: Common Stock · 162,540 shares Expires 2035-01-02 F4 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2026, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 23:59 UTC |
Watts Ryan J.Director · President and CEO
|
GrantCommon Stock | 54,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-25-000028 · wk-form4_1736294379.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,987 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2026 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · balance_after: Includes 192,940 Unvested RSUs. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 23:57 UTC |
Schuth Alexander O.COFO and Secretary
|
GrantStock Option (right to buy) · Derivative | 162,540 | $0.00 Strike: $21.26 | $0.00 |
DisclosureSEC source: 0001714899-25-000027 · wk-form4_1736294268.xml · derivative · entry 3 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,540 Underlying: Common Stock · 162,540 shares Expires 2035-01-02 F4 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2026, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 23:57 UTC |
Schuth Alexander O.COFO and Secretary
|
GrantCommon Stock | 54,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-25-000027 · wk-form4_1736294268.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,470 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2026 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · balance_after: Includes 141,530 Unvested RSUs. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 23:56 UTC |
Ho CaroleChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 162,540 | $0.00 Strike: $21.26 | $0.00 |
DisclosureSEC source: 0001714899-25-000026 · wk-form4_1736294172.xml · derivative · entry 4 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,540 Underlying: Common Stock · 162,540 shares Expires 2035-01-02 F5 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2026, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 23:56 UTC |
Ho CaroleChief Medical Officer
|
GrantCommon Stock | 54,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-25-000026 · wk-form4_1736294172.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,835 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2026 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · balance_after: Includes 141,530 Unvested RSUs. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:13 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 3,080 | $20.91 | $64,402.80 |
DisclosureSEC source: 0001714899-25-000001 · wk-form4_1735938823.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,976 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $20.75 to $21.06 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:14 UTC |
Krognes Steve E.Director
|
SaleCommon Stock | 30,000 | $20.25 | $607,500.00 |
DisclosureSEC source: 0001714899-25-000002 · wk-form4_1735938858.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,096 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted December 1, 2023. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $20.10 to $20.55 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects an allocation of 30,000 shares from the Steven Edward Krognes Revocable Trust to the Reporting Person. F4 · balance_after: Includes 13,467 Unvested RSUs. Read SEC document |
| December 27, 2024 Filed Dec 31, 2024 21:18 UTC |
Schuth Alexander O.COFO and Secretary
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,708 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001714899-24-000236 · wk-form4_1735679885.xml · derivative · entry 3 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,671 Underlying: Common Stock · 6,708 shares Expires 2027-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| December 27, 2024 Filed Dec 31, 2024 21:18 UTC |
Schuth Alexander O.COFO and Secretary
|
Exercise / conversionCommon Stock | 6,708 | $5.28 | $35,418.24 |
DisclosureSEC source: 0001714899-24-000236 · wk-form4_1735679885.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 118,810 Unvested RSUs. Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 21:44 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,845 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001714899-24-000235 · wk-form4_1732743876.xml · derivative · entry 4 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,155 Underlying: Common Stock · 17,845 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days. Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 21:44 UTC |
Ho CaroleChief Medical Officer
|
Exercise / conversionCommon Stock | 17,845 | $0.68 | $12,134.60 |
DisclosureSEC source: 0001714899-24-000235 · wk-form4_1732743876.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 118,810 Unvested RSUs. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 22:19 UTC |
Schuth Alexander O.COFO and Secretary
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,516 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001714899-24-000234 · wk-form4_1732659560.xml · derivative · entry 3 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,562 Underlying: Common Stock · 20,516 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 22:19 UTC |
Schuth Alexander O.COFO and Secretary
|
Exercise / conversionCommon Stock | 20,516 | $0.68 | $13,950.88 |
DisclosureSEC source: 0001714899-24-000234 · wk-form4_1732659560.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Includes 118,810 Unvested RSUs. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:18 UTC |
Schenkein David PDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 47,165 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000219 · wk-form4_1731532732.xml · derivative · entry 6 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,165 shares Expires 2027-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 25% of the shares subject to the option shall vest on December 7, 2018 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:18 UTC |
Schenkein David PDirector
|
SaleCommon Stock | 32,312 | $32.87 | $1,062,095.44 |
DisclosureSEC source: 0001714899-24-000219 · wk-form4_1731532732.xml · nonDerivative · entry 3 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,220 F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted August 12, 2024. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $32.54 to $33.28 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes 5,967 Unvested RSUs. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:18 UTC |
Schenkein David PDirector
|
SaleCommon Stock | 27,129 | $32.09 | $870,569.61 |
DisclosureSEC source: 0001714899-24-000219 · wk-form4_1731532732.xml · nonDerivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,532 F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted August 12, 2024. F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.54 to $32.53 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes 5,967 Unvested RSUs. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:18 UTC |
Schenkein David PDirector
|
Exercise / conversionCommon Stock | 47,165 | $18.00 | $848,970.00 |
DisclosureSEC source: 0001714899-24-000219 · wk-form4_1731532732.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,967 Unvested RSUs. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:44 UTC |
Schuth Alexander O.COFO and Secretary
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,558 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001714899-24-000218 · wk-form4_1731447884.xml · derivative · entry 6 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,379 Underlying: Common Stock · 15,558 shares Expires 2027-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:44 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 300 | $31.29 | $9,387.00 |
DisclosureSEC source: 0001714899-24-000218 · wk-form4_1731447884.xml · nonDerivative · entry 4 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 178,066 F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.27 to $31.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes 118,810 Unvested RSUs. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:44 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,925 | $30.72 | $89,856.00 |
DisclosureSEC source: 0001714899-24-000218 · wk-form4_1731447884.xml · nonDerivative · entry 3 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 178,366 F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.21 to $31.17 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes 118,810 Unvested RSUs. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:44 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 12,333 | $29.68 | $366,043.44 |
DisclosureSEC source: 0001714899-24-000218 · wk-form4_1731447884.xml · nonDerivative · entry 2 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 181,291 F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023. F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.21 to $30.20 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes 118,810 Unvested RSUs. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:44 UTC |
Schuth Alexander O.COFO and Secretary
|
Exercise / conversionCommon Stock | 15,558 | $5.28 | $82,146.24 |
DisclosureSEC source: 0001714899-24-000218 · wk-form4_1731447884.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 193,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 118,810 Unvested RSUs. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:43 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,020 | $30.00 | $30,600.00 |
DisclosureSEC source: 0001714899-24-000217 · wk-form4_1731447801.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,056 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024. F2 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:21 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 3,080 | $27.07 | $83,375.60 |
DisclosureSEC source: 0001714899-24-000208 · wk-form4_1730841680.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,076 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $26.60 to $27.41 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
| October 18, 2024 Filed Oct 22, 2024 20:30 UTC |
Watts Ryan J.Director · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001714899-24-000206 · wk-form4_1729629050.xml · derivative · entry 4 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,078,091 Underlying: Common Stock · 40,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days. Read SEC document |
| October 18, 2024 Filed Oct 22, 2024 20:30 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 40,000 | $27.69 | $1,107,600.00 |
DisclosureSEC source: 0001714899-24-000206 · wk-form4_1729629050.xml · nonDerivative · entry 2 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 235,807 F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023. F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $27.49 to $28.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes 197,200 Unvested RSUs. Read SEC document |
| October 18, 2024 Filed Oct 22, 2024 20:30 UTC |
Watts Ryan J.Director · President and CEO
|
Exercise / conversionCommon Stock | 40,000 | $0.68 | $27,200.00 |
DisclosureSEC source: 0001714899-24-000206 · wk-form4_1729629050.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 275,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 197,200 Unvested RSUs. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:37 UTC |
Krognes Steve E.Director
|
SaleCommon Stock | 30,000 | $29.03 | $870,900.00 |
DisclosureSEC source: 0001714899-24-000200 · wk-form4_1727901447.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,096 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted December 1, 2023. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.50 to $29.32 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects an allocation of 26,419 shares from the Steven Edward Krognes Revocable Trust to the Reporting Person. F4 · balance_after: Includes 13,467 Unvested RSUs. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:17 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,020 | $30.00 | $30,600.00 |
DisclosureSEC source: 0001714899-24-000199 · wk-form4_1726517865.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,156 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024. F2 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.